Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

The vaccine triggered a satisfactory immune response against the pathogen in ... "Most vaccines are based on attenuated or inactivated viruses, but our next-generation strategy enables us to ...

The use of adjuvants with immunopotentiating properties that can direct the immune responses to humoral ... pathogenic than the real pathogen; inactivated vaccines that are heat-inactivated ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight advanced kidney cancer. A team of researchers, led by Dr David Braun ...

The development of an effective HIV vaccine remains an urgent public health need due to the high genetic variability and rapid mutation rates of the virus, which limit the generation of broadly ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.